Back
Speaker illustration

Doctor Maria Ferre-Vallverdu

University Hospital Sant Joan de Reus, Reus (Spain)

Presentations

High prevalence of progression of structural and functional abnormalities in a cohort at -risk for heart failure. Report from the STOP HF cohort.

Event: Heart Failure 2019

Topic: Prevention

Session: Rapid Fire 7 - Improving our insights: biomarkers, imaging, scores

Access
Like
Thumbnail

Careful volume assessment appears to be the critical factor in achieving clinical trial dose of sacubitril/valsartan in the community.

Event: Heart Failure 2019

Topic: Pharmacotherapy

Session: Chronic Heart Failure – Treatment

Access
Like
Thumbnail

ESC 365 is supported by

novartis Explore sponsored resources